openPR Logo
Press release

Recombinant Factor C Assay Market Recent News Global Trend, Gross Earning and Emerging Growth Opportunity by 2027

05-19-2020 05:58 PM CET | Health & Medicine

Press release from: Transparency Market Research

Recombinant Factor C Assay Market Recent News Global Trend,

Recombinant Factor C Assay Market: Introduction

According to the report, the global recombinant factor C assay market was valued at ~US$ 13 Mn in 2018 and is projected to expand at a considerable CAGR during the forecast period. Recombinant factor C (rFC) assay can be defined as an alternative to LAL tests employed for endotoxin testing of the products for pyrogens. These tests are performed on all the pharmaceutical products and medical devices in batches prior to their release for human use. This method of endotoxin testing employs a single enzymatic step compared to multiple steps enzymatic process needed for LAL assays. Rise in need for alternative endotoxin detection tests drives the global recombinant factor C assay market. Commonly used tests for the detection of endotoxins include limulus amoebocyte lysate (LAL) test and rabbit pyrogen test. However, decline in horseshoe crab population and increasing threat of their extinction have led to the development of newer tests such as the recombinant factor C (rFC) test that employs the recombinant factor C, which is one of the major components of the cascade of proteins tested during the LAL detection tests.

North America dominated the global recombinant factor C assay market in 2018 and the trend is anticipated to continue during the forecast period. Strong growth of the market in the region can be attributed to incorporation of the rFC assays in the U.S. pharmacopoeia, strong presence of market players in the region, and increase in adoption of rFC assays by the pharmaceutical companies in the region.

Get PDF Sample Copy of Report: (Including TOC, List of Tables & Figures, Chart) : https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=36044

Advantages of Recombinant Factor C Assay

Recombinant factor C (rFC) assays are being considered to be replacements for the most employed endotoxin detection method, the LAL test. This can be attributed to the higher specificity, greater sensitivity, and lesser variability of recombinant factor C tests compared to other endotoxin detection methods. Advantages offered by the recombinant factor C tests include the ability to perform comparably or better than LAL/TAL-based methods for various applications, lot-to-lot consistency, ease-of-use & a suitable sensitivity range, and enhanced endotoxin specificity. These advantages would encourage the pharmaceutical product manufacturers to employ alternative tests such as the recombinant factor C assays. In addition, the adoption of this assays will contribute significantly in the conservation of horseshoe crabs, which are considered as "living fossils". This, in turn, is likely to boost the growth of the global market.

PyroGene to Lead Global Market

In terms of brand segment, the PyroGene brand is likely to account for a major share of the global recombinant factor C assay market during the forecast period. The growth of the segment can be attributed to it being the first marketed recombinant Factor C assay product employed as an alternative to LAL tests. It is one of the major products tested as an alternative to LAL tests with an aim of conserving the Limulus species, which is considered as a "Living Fossil".

REQUEST FOR COVID19 IMPACT ANALYSIS - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=36044

Recombinant Factor C Assay Market: Prominent Regions

The global recombinant factor C assay market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global recombinant factor C assay market in 2018. The expansion of the recombinant factor C assay market in the region can be attributed to well-established presence of the market players, changing government regulations, and introduction of recombinant factor C as an alternative assay for LAL endotoxin detection. In addition, increase in product approvals by the U.S. FDA is likely to create a demand for recombinant factor C assays, owing to the fact that endotoxin detection is the mandatory process prior to the launch of the products for human use.

The recombinant factor C assay market in Asia Pacific is likely to expand at a high CAGR from 2019 to 2027. Growth of the market in the region can be attributed to changing regulations, inclusion of recombinant factor C assays in global pharmacopoeias, growing pharmaceutical and biotechnology industries, and rise in medical tourism.

Read our Case study at : https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

Global Recombinant Factor C Assay Market: Segmentation

Recombinant Factor C Assay Market, by BrandPyroGenePyroGene Bulk rFC (2,880 Tests)
PyroGene rFC (192 Tests)
EndoNextEndozyme II
Endozyme II GO
EndoLisa
Recombinant Factor C Assay Market, by End UserPharmaceutical Companies
Biotechnology Companies
Medical Device Companies
Contract Research Organizations (CROs)
Recombinant Factor C Assay Market, by RegionNorth AmericaU.S.
Canada
EuropeU.K.
Germany
France
Italy
Spain
Rest of Europe
Asia PacificChina
India
Japan
Australia
Rest of Asia Pacific
Latin AmericaBrazil
Mexico
Rest of Latin America
Middle East & AfricaGCC Countries
South Africa
Rest of Middle East & Africa
More Trending Reports by Transparency Market Research - 1. http://www.prnewswire.com/news-releases/animal-health-gains-prominence-as-role-shifts-from-pets-to-companions-contributing-to-growth-in-veterinary-radiography-system-market-notes-tmr-301022155.html

2. https://www.biospace.com/article/gemcitabine-hcl-market-generic-segment-expected-to-grow-at-a-rapid-pace-in-the-market/

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Recombinant Factor C Assay Market Recent News Global Trend, Gross Earning and Emerging Growth Opportunity by 2027 here

News-ID: 2051327 • Views:

More Releases from Transparency Market Research

Automotive Thermal Management System Market Poised to Reach USD 173.8 Billion by 2036, Driven by EV Adoption and Advanced Thermal Technologies
Automotive Thermal Management System Market Poised to Reach USD 173.8 Billion by …
The global automotive thermal management system market is entering a high-growth phase, fueled by the rapid electrification of vehicles, stricter emission norms, and rising expectations for vehicle safety, comfort, and efficiency. Valued at US$ 82.6 billion in 2025, the market is projected to nearly double and reach US$ 173.8 billion by 2036, expanding at a robust CAGR of 6.8% from 2026 to 2036. Thermal management has become a mission-critical function in
Thermal-Management Exterior Coatings for High-Altitude Aircraft Market to be Worth USD 9.8 Bn by 2036 - By Coating Functionality / By Material / By End-User | U.S. • Canada • Germany • China • India
Thermal-Management Exterior Coatings for High-Altitude Aircraft Market to be Wor …
The global Thermal-Management Exterior Coatings for High-Altitude Aircraft Market was valued at US$ 1.8 Bn in 2025 and is projected to reach US$ 9.8 Bn by 2036, expanding at a robust CAGR of 17.5% during the forecast period from 2026 to 2036. Review critical insights and findings from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86920 This strong growth trajectory reflects the rising importance of advanced exterior coating technologies that ensure aircraft performance, safety,
Epithelioma Treatment Market Outlook 2035: Rising Skin Cancer Burden, Breakthrough Immunotherapies, and an 8.8% CAGR Growth Trajectory
Epithelioma Treatment Market Outlook 2035: Rising Skin Cancer Burden, Breakthrou …
The global epithelioma treatment market has entered a decisive growth phase, supported by rising cancer prevalence and rapid therapeutic innovation. In 2024, the market was valued at US$ 5.1 Bn, reflecting the growing demand for advanced diagnostic and therapeutic solutions targeting epithelial-origin tumors. Over the forecast period from 2025 to 2035, the industry is projected to expand at a robust compound annual growth rate (CAGR) of 8.8%, reaching a valuation
Tablet Hardness Testers Market to Reach USD 427.9 Mn by 2036, Driven by Rising Pharmaceutical Quality Standards
Tablet Hardness Testers Market to Reach USD 427.9 Mn by 2036, Driven by Rising P …
The Tablet Hardness Testers Market is a critical part of the pharmaceutical quality-control ecosystem. Tablet hardness testers are used to measure the mechanical strength of tablets to ensure they can withstand handling, packaging, transportation, and storage without breaking, while still dissolving correctly once ingested. As regulatory oversight becomes stricter and pharmaceutical production expands globally, the demand for accurate and reliable hardness testing equipment continues to rise. The global Tablet Hardness Testers

All 5 Releases


More Releases for Recombinant

Recombinant Human Endostatin Market Experiences Surge Due to Innovations in Reco …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Recombinant Human Endostatin Market - (By Type (purity 95% and others) And By Application (medical care, scientific research and others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global Recombinant Human Endostatin Market is valued at US$ 133.3 Mn in 2023, and it is expected to
Recombinant Chemicals Market Expands with Growing Adoption of Recombinant DNA an …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Recombinant Chemicals Market - (By Product Type (Recombinant Proteins, Recombinant DNAs, Recombinant Peptides, Others), By Technology (Microbial Expression Systems, Mammalian Cell Expression Systems, Yeast Expression Systems, Insect Cell Expression Systems, Cell-free Expression Systems), By Application (Drug Development, Vaccine Production, Therapeutics, Cell Line Development, Agriculture, Food and Beverage, Others)), Trends, Industry Competition Analysis, Revenue and Forecast
Recombinant Collagen Market Size and Forecast
Recombinant Collagen Market size was valued at USD 0.9 Billion in 2022 and is projected to reach USD 1.8 Billion by 2030, growing at a CAGR of 9.0% from 2024 to 2030. Recombinant Collagen Market Outlook and Investment Analysis Top companies Giant Biogene Holding, Avantor, ProColl, Merck, ACROBiosystems, Wuhan Fine Biotech, Shanxi Jinbo Bio-Pharmaceutical, Jiangsu Jland Biotech, Jiangsu Trautec Medical Technology, OriGene Technologies Recombinant Collagen Market: Trends & Investment Analysis Market Growth: The recombinant collagen
Global Recombinant Cell Culture Supplements Market Size - By Product Type(Recomb …
Recombinant Cell Culture Supplements Market Insights: Trends, Drivers, and Outlook 2024 - 2031 Recombinant Cell Culture Supplements Market Scope: Unveiling Today's Trends Recombinant Cell Culture Supplements are specialized products designed to enhance growth and productivity in cells used for research and bioproduction. The market for these supplements is experiencing substantial growth, driven by the rising demand for biopharmaceuticals and advancements in biotechnology. Increasing investments in research and development activities also contribute to market
Recombinant Protein Market Size, Share | Recombinant Protein Industry Future Gro …
Global Recombinant Protein Market Report provides a detailed industry overview along with the analysis of Cost Structure, Supply Chain, Development Techniques, Retailers Analysis, Financial Support, business Strategies, Marketing Channels. Global Recombinant Protein Market research report provides a point-by-pointIn-Depth analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players, value chain optimization, trade regulations,
Recombinant Proteins Market 2022 | Recombinant Proteins Market: Global Industry …
Recombinant proteins play an imperative role in treating various diseases, such as hemophilia. Majority of the recombinant proteins used are human proteins, in order to compensate the functional proteins in vivo defects by increasing the protein function in a body. This Research Report Insights analyzes the expansion of global recombinant protein market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022. The next